STAGE III RENAL CELL CANCER AJCC V8
Clinical trials for STAGE III RENAL CELL CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE III RENAL CELL CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE III RENAL CELL CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Zapping tumors: wearable device tested with drugs for tough cancers
Disease control Recruiting nowThis early-stage trial is testing the safety of combining a wearable device that uses electric fields to disrupt cancer cells with different drug combinations. It is for adults with advanced cancers in the abdomen or chest that have spread and who have run out of standard treatme…
Matched conditions: STAGE III RENAL CELL CANCER AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Precision radiation blast tested to boost Cancer-Fighting drugs
Disease control Recruiting nowThis study is for people with advanced kidney cancer that has spread and is not recommended for surgery. It tests whether adding a short, highly focused course of radiation to the main kidney tumor, while patients receive standard immunotherapy drugs, helps control the cancer bet…
Matched conditions: STAGE III RENAL CELL CANCER AJCC V8
Phase: PHASE2 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Gut bacteria joins fight against advanced kidney cancer
Disease control Recruiting nowThis early-stage study is testing whether adding a specific gut bacteria supplement, called EXL01, makes standard immunotherapy drugs (nivolumab and ipilimumab) safer and more effective for people with advanced kidney cancer that has spread. The goal is to see if changing the gut…
Matched conditions: STAGE III RENAL CELL CANCER AJCC V8
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Custom-Made vaccine aims to train immune system to fight advanced cancers
Disease control Recruiting nowThis study is testing a new, personalized vaccine designed to target the unique proteins on a patient's own cancer cells. It is being given alongside an existing immunotherapy drug (pembrolizumab) to see if the combination is safe and can help control advanced solid tumors that h…
Matched conditions: STAGE III RENAL CELL CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
Cancer care comes home: mayo clinic tests At-Home immunotherapy shots
Disease control Recruiting nowThis study is testing whether giving a cancer immunotherapy treatment called nivolumab as an injection at home is a safe and practical alternative to receiving it at a clinic. It aims to see if home treatment reduces the burden of travel and improves quality of life for patients …
Matched conditions: STAGE III RENAL CELL CANCER AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 16, 2026 15:27 UTC
-
Three-Pronged attack on tough kidney cancers
Disease control Recruiting nowThis study is testing a combination of three drugs—bevacizumab, erlotinib, and atezolizumab—to see if they can control or shrink advanced kidney cancers linked to a hereditary condition (HLRCC) or a specific type called papillary renal cell cancer. The trial aims to enroll 65 pat…
Matched conditions: STAGE III RENAL CELL CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 10, 2026 12:54 UTC
-
Gut health boost joins fight against advanced kidney cancer
Disease control Recruiting nowThis study is testing whether adding a gel made from inulin, a common dietary fiber, makes standard immunotherapy drugs more effective for people with advanced kidney cancer. Researchers think improving gut bacteria health might help the immune system fight cancer better. The tri…
Matched conditions: STAGE III RENAL CELL CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Feb 25, 2026 15:08 UTC
-
Mayo clinic tests 'Crystal Ball' for cancer treatment success
Knowledge-focused Recruiting nowThis study aims to collect tumor tissue samples from patients with various cancers to test a new diagnostic platform called Elephas. The goal is to see how accurately this tool can predict whether patients will respond to immunotherapy treatments before they begin. Researchers wi…
Matched conditions: STAGE III RENAL CELL CANCER AJCC V8
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:26 UTC